Dental Education & Research

Postoperative Pain Relief in Dentistry - Part 1

(This article is part 1 of the 2-part series on postoperative pain relief in dentistry) Abstract Pain is one of the main problems in the early postoperative...

Dr. Rockson Samuel

Dr. Rockson Samuel

Founder & Chief Dentist · Indira Dental Clinic; DentalReach

8 min read19,572 views
  • analgesics
  • professional education
  • nsaids
  • pain management
  • pain relief mechanisms
  • dentistry
  • nonsteroidal anti-inflammatory drugs
  • postoperative pain
  • Dental Education & Research
  • Clinical & Academic Article

(This article is part 1 of the 2-part series on postoperative pain relief in dentistry)

Abstract

Pain is one of the main problems in the early postoperative period at the completion of the surgical intervention, after the effect of local anesthetics wears off. For its treatment in modern outpatient practice, non-narcotic analgesics are used, which, in addition to the analgesic effect, have antipyretic, anti-inflammatory and desensitizing properties. This part describes them in detail - their names, types, mechanisms, pharmacokinetics, pharmacodynamics and side effects.

The best analgesic in dentistry

Analgesic ("pain reliever") is a medicinal substance of natural, semi-synthetic or synthetic origin, intended to relieve pain - analgesia .

Non-steroidal anti-inflammatory drugs (NSAIDs, also called non-narcotic analgesics) is a group of drugs that have analgesic, antipyretic, desensitizing and anti-inflammatory effects, and reduces pain, fever and inflammation.

The use of the term "nonsteroidal anti-inflammatory" in the name emphasizes their difference from glucocorticoids, which have not only an anti-inflammatory effect, but also other, sometimes undesirable, properties of steroids.

The term “non-narcotic analgesics” is appropriate because these drugs reduce the perception of pain without a noticeable disruption of other functions of the central nervous system and are devoid (unlike narcotic analgesics) of a psychotropic effect (and hence the patient becomes addicted to them), a depressing effect on nerve centers, which allows them to be used more widely, for a long time, as well as in outpatient practice.

NSAIDs are characterized by:

  • a non-specific anti-inflammatory action, that is, an inhibitory effect on any inflammatory process, regardless of its etiological and pathological features
  • relatively good tolerance associated with their rapid elimination from the body
  • in therapeutic doses - an inhibitory effect on platelet aggregation and the interaction of immunocompetent cells
  • binding to plasma albumins with competition between different drugs for binding sites.

Mechanism of Action

In non-narcotic analgesics, a certain role is played by their effect on the thalamic centers, which leads to inhibition of the conduction of pain impulses in the cerebral cortex. By the nature of the central action, these analgesics differ from narcotic ones in that they do not affect the ability of the central nervous system in summation of subcortical impulses.

Non-narcotic vs narcotic drugs

Non-narcotic analgesics in their pharmacological properties differ significantly from analgesics of the narcoticmorphine group. These drugs are significantly inferior to narcotic painkillers in terms of the strength of the analgesic effect. Non-narcotic analgesics

  • do not depress breathing
  • do not cause euphoria
  • do not cause drug dependence
  • do not have a hypnotic effect
  • do not affect the cough center

In this group of drugs, anti-inflammatory and antipyretic effects are clearly manifested, which narcotic analgesics do not have. The advantage of these drugs is the absence of a narcotic effect, which gave reason to widely use them in outpatient practice.

Classification & Types

Non-narcotic analgesics are classified according to their chemical structure:

1. Salicylic acid derivatives: Representatives of this group are characterized by low toxicity. LD50 (semi-lethal dose - the average dose of a substance that causes the death of half the members of the test group) of acetylsalicylic acid is 120 g. They have a prolonged anti-inflammatory and analgesic effect. However, they have a noticeable irritant effect (risk of ulceration and bleeding). Preparations of this group are contraindicated in children under 12 years of age.

Examples -

  • acetylsalicylic acid (aspirin)
  • lysine acetylsalicylate (acelysin)
  • sodium salicylate
  • methyl salicylate
  • salicylamide
  • viox (difiunisal - a derivative of salicylic acid)

2. Pyrazolone derivatives:
The drugs have a small breadth of therapeutic action, they inhibit hematopoiesis, therefore they are not prescribed for a long time.

Examples -

  • amidopyrine (aminophenazone)
  • metamizole sodium (analgin)
  • phenylbutazone (butadione)
  • phenazone (antipyrine)

Analgin, due to its good water solubility, is used intramuscularly, subcutaneously and intravenously for emergency pain relief and the treatment of hyperthermia. Amidopyrine increases convulsive readiness in young children and reduces diuresis.

3. Para-aminophenol derivatives:
Representatives of this group lack anti-inflammatory activity, antiplatelet and antirheumatic effects. Practically do not cause ulceration, do not inhibit kidney function, do not increase convulsive activity of the brain.

Examples -

  • phenacetin
  • paracetamol

Paracetamol is the drug of choice in the treatment of hyperthermia, especially in children. Phenacetin with prolonged use causes nephritis.

4. Derivatives of organic acids:

  • Phenylacetic - sodium diclofenac (ortofen, voltaren).
    This drug rarely causes ulceration and is mainly used as an anti-inflammatory and antirheumatic agent.
  • Phenylpropionic - ibuprofen, naproxen, ketoprofen, pirprofen, thiaprofenic acid (thiaprofen).
    Ibuprofen is similar to diclofenac; naproxen and pyroprofen give a greater anti-inflammatory effect; thiaprofen shows greater selectivity in suppressing the synthesis of PG F2-alpha (less often it has side effect on the bronchi, gastrointestinal tract and uterus).
  • Indolacetic - metindol (indomethacin), sulindac, selective COX-2 inhibitor - stodolac.
    Indomethacin is the standard in terms of anti-inflammatory activity (maximum), but interferes with the metabolism of brain mediators (reduces GABA levels) and provokes insomnia, agitation, hypertension, convulsions, exacerbation of psychosis. Sulindac turns into indomethacin in the patient's body, has a longer and slower action.
  • Anthranilic (fenamic): mefenamic acid, flufenamic acid.
    Mefenamic acid is used primarily as an analgesic and antipyretic; niflumic acid in its properties is close to mefenamic acid; flufenamic is used as an anti-inflammatory agent (weak analgesic).
  • Pyrrolizinecarboxylic - ketorolac. It has a pronounced analgesic effect.

Free for members

Keep reading — it's free

The rest of this article is open to DentalReach members. Create a free account, or sign in, and every article on the site opens in full.

One email on Tuesdays: new articles, discussions, events and jobs. Unsubscribe in one click.

Topics

References

  1. [1]American Dental Association. Acute Dental Pain Management Guideline ADA Evidence-Based Dentistry. 2024. Available at: source
  2. [2]American Dental Association. Oral Analgesics for Acute Dental Pain ADA Oral Health Topics. Available at: source

Written by

Dr. Rockson Samuel

Dr. Rockson Samuel

Founder & Chief Dentist · Indira Dental Clinic; DentalReach

Dr. Rockson Samuel is a dental surgeon, healthcare content strategist, and Founder and Chief Dentist of Indira Dental Clinic in Vellore, Tamil Nadu. He provides comprehensive general and family dental care with professional interests in endodontics, implant dentistry, clear aligner therapy, digital dentistry, preventive care and patient education. A graduate of K.G.F. College of Dental Sciences and Hospital under Rajiv Gandhi University of Health Sciences, he also has formal training in management and digital marketing. As Community Leader at DentalReach, he contributes to dental publishing, professional education, international media partnerships and the development of evidence-informed resources for dentists.

Have a question about this article?

Ask DentalReach for a sourced answer from the library. It cannot provide personal medical advice.

Ask about this article